Real-time enrollment status for this amyotrophic lateral sclerosis clinical trial
Current Status
Active, Not Recruiting
Checked: March 2, 2026 at 11:51 AM UTC
| NCT Number | NCT06643481 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Amyotrophic Lateral Sclerosis |
| Phase | Clinical Trial |
| Target Enrollment | 225 participants |
| Active Locations | 13 sites in the US |
| Sponsor | Novartis Pharmaceuticals |
| Last Updated on CT.gov | November 12, 2025 (Nov 12, 2025) |
As of March 2, 2026: Clinical trial NCT06643481 is currently active_not_recruiting participants. This clinical trial study for amyotrophic lateral sclerosis is not currently accepting new participants at 13 locations across the United States. The study is sponsored by Novartis Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06643481 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 13 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06643481 was last updated Nov 12, 2025 (November 12, 2025). HelloStudys verifies this status automatically.